Data from a 2021 crossover study showed, however, that both TRS and ultra-treatment-resistant Sch (UTRS) patients tended to increase TNFα expression, which, however, did not reach statistical significance [ 108 ]. 3.1.3.
1
—
—
Data from a 2021 crossover study showed, however, that both TRS and ultra-treatment-resistant Sch (UTRS) patients tended to increase TNFα expression, which, however, did not reach statistical significance [ 108 ]. 3.1.3.